Compounds > lopinavir
Page last updated: 2024-08-26

lopinavir and Chronic Disease

lopinavir has been researched along with Chronic Disease in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Chen, M; Chen, Z; Gao, G; Ma, X; Qian, F; Wang, A; Wang, S; Wang, X; Yu, F; Zhang, F; Zhang, J; Zhao, T1
Aguirrebengoa, K1
Post, FA1
Heinz, W; Hubert, C; Klinker, H; Langmann, P; Leyh, M; Schnaitmann, E; Trein, A; Winzer, R1
Chaisson, RE; Mehta, SH; Moore, RD; Sulkowski, MS; Thomas, DL1

Reviews

1 review(s) available for lopinavir and Chronic Disease

ArticleYear
Managing chronic kidney disease in the older adults living with HIV.
    Current opinion in infectious diseases, 2017, Volume: 30, Issue:1

    Topics: Adult; Aged; Anti-HIV Agents; Atazanavir Sulfate; Chronic Disease; Darunavir; Drug Substitution; HIV Infections; Humans; Kidney; Kidney Diseases; Lopinavir; Middle Aged; Tenofovir

2017

Other Studies

4 other study(ies) available for lopinavir and Chronic Disease

ArticleYear
Brief Report: Retrospective Evaluation on the Efficacy of Lopinavir/Ritonavir and Chloroquine to Treat Nonsevere COVID-19 Patients.
    Journal of acquired immune deficiency syndromes (1999), 2020, 10-01, Volume: 85, Issue:2

    Topics: Adult; Antimalarials; Chloroquine; Chronic Disease; Coronavirus Infections; COVID-19; Drug Combinations; Female; Fever; HIV Protease Inhibitors; Humans; Lopinavir; Male; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; Ritonavir; Treatment Outcome; Young Adult

2020
[Challenges of lopinavir/ritonavir in the chronicity of human immunodeficiency virus infection].
    Enfermedades infecciosas y microbiologia clinica, 2014, Volume: 32 Suppl 3

    Topics: Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Chronic Disease; Comorbidity; Drug Combinations; Drug Costs; HIV Infections; HIV Integrase Inhibitors; HIV Protease Inhibitors; Humans; Lopinavir; Medication Adherence; Meta-Analysis as Topic; Multicenter Studies as Topic; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir

2014
Safety of long-term lopinavir plasma-levels in patients with liver disease.
    European journal of medical research, 2008, May-26, Volume: 13, Issue:5

    Topics: Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Chromatography, High Pressure Liquid; Chronic Disease; Drug Monitoring; Female; Humans; Liver Diseases; Lopinavir; Male; Middle Aged; Pyrimidinones; Retrospective Studies

2008
Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir.
    AIDS (London, England), 2004, Nov-19, Volume: 18, Issue:17

    Topics: Adult; AIDS-Related Opportunistic Infections; Antiretroviral Therapy, Highly Active; Chronic Disease; Drug Therapy, Combination; Female; Hepatitis; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Liver; Lopinavir; Male; Nelfinavir; Prospective Studies; Pyrimidinones; Reverse Transcriptase Inhibitors; Risk Factors; Ritonavir; Saquinavir; Treatment Outcome

2004